Tasquinimod-d3 | MedChemExpress (MCE)
Tasquinimod-d3 (ABR-215050-d3) is the deuterium labeled Tasquinimod (HY-10528). Tasquinimod is an oral antiangiogenic agent, which plays an important role in castration-resistant prostate cancer. Tasquinimod binds to the regulatory Zn2+ binding domain of HDAC4 with Kd of 10-30 nM. Tasquinimod also is a S100A9 inhibitor[1][2][3].
| Trivial name | Tasquinimod-d3 |
| Catalog Number | HY-10528S |
| Alternative Name(s) | ABR-215050-d3 |
| Research Area | Cancer |
| CAS# | 1416701-99-9 |
| Purity | 99.0% |
| SMILES | O=C(N(C1=CC=C(C=C1)C(F)(F)F)C([2H])([2H])[2H])C2=C(C3=C(C=CC=C3OC)N(C2=O)C)O |
| Size | 5 mg |
| Supplier Page | https://www.medchemexpress.com/tasquinimod-d3.html |